Navigation Links
Cell dysfunction linked to obesity and metabolic disorders
Date:9/26/2011

By measuring the radioactive isotope carbon-14, scientists at Karolinska Institutet have revealed an association between lipid cell dysfunction and diseases such as obesity, diabetes and blood lipid disorders. The study, which is presented in the journal Nature, can lead to new approaches to combating metabolic diseases.

The results show that fat cells in overweight people have a higher capacity for storing fats but a lower capacity for ridding themselves of them.

"One might intuitively think that this was the case," says Peter Arner, who led the study together with Kirsty Spalding. "But this is the first time that someone has demonstrated that the metabolism of fat in the fat cells differs between healthy and obese individuals. This paves the way for new research fields and therapies that affect the storage and release of fat from fat cells."

The researchers used tissue samples from almost 100 people, ranging in weight from slim to massively obese. By ascertaining the age of the fat in the fat cells, they were able to draw conclusions on how the fat is stored and removed from the fat mass over time. The method for determining the age of the fat in fat cells is based on the incorporation of radioactive carbon-14 from the atmosphere into the body. Cold War nuclear testing caused a sharp increase in atmospheric carbon-14, which has gradually declined since testing stopped.

"We can use measurements of carbon-14 in fat against known levels of 14C in the atmosphere to date stamp the fat," says Dr Spalding, the developer of the method for examining fat tissue and other biological samples.

The researchers concluded that the fat stored in the fat cells of healthy people is renewed on average six times during the ten years of a fat-cell's lifespan. On the other hand, people with a preliminary stage of type II diabetes (insulin resistance) showed a reduced ability to rid their fat cells of fat.

This also applied to people with familial combined hyperlipidemia, a common form of congenital blood lipid disorder associated with a high risk of coronary artery disease. These people, however, also displayed a reduced ability to store fat in their fat cells. When the metabolism is upset in this way, it could mean that the concentration of triglycerides and cholesterol in the blood rises.


'/>"/>

Contact: Press Office
pressinfo@ki.se
46-852-486-077
Karolinska Institutet
Source:Eurekalert

Related biology news :

1. USC researchers identify gene variant associated with both autism and gastrointestinal dysfunction
2. Study shows male erectile dysfunction drug enhances fetal growth in female sheep
3. Hormonal contraceptives associated with higher risk of female sexual dysfunction
4. Protein could heal erectile dysfunction after cancer surgery
5. Circadian rhythms: Their role and dysfunction in affective disorder
6. How immune response in pregnancy may lead to brain dysfunction in offspring
7. The aging brain and Alzheimers disease: New ideas for targeting synaptic dysfunction
8. Noninvasive wireless near-infrared device provides reliable diagnosis of bladder dysfunction
9. Breast cancer treatment resistance linked to signaling pathway
10. Lack of vitamin D linked to Parkinsons disease
11. Resveratrol, red wine compound linked to health, also found in dark chocolate and cocoa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , Dec. 1, 2016   SoftServe ... announced BioLock , an electrocardiogram (ECG) biosensor ... monitoring, a key IoT asset. The smart system ... a vehicle,s steering wheel and mobile devices to ... touch. As vehicle technology advances, so ...
(Date:11/29/2016)... -- Nearly one billion matches per second with DERMALOG,s high-speed ... ... DERMALOG is Germany's largest Multi-Biometric supplier: ... (PRNewsFoto/DERMALOG Identification Systems) ... is Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is part ...
(Date:11/21/2016)... Nov. 21, 2016   Neurotechnology , a ... technologies, today announced that the MegaMatcher On Card ... submitted for the NIST Minutiae Interoperability Exchange ... the mandatory steps of the evaluation protocol. ... continuing test of fingerprint templates used to establish ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  HedgePath Pharmaceuticals, Inc. ... discovers, develops and plans to commercialize innovative therapeutics ... of common stock were approved for trading on ... trading on the OTCQX, effective today, under the ... the OTCQX market, companies must meet high financial ...
(Date:12/8/2016)... 8, 2016 Eutilex Co. Ltd. today announced ... $18.9M) Series A financing. This financing round included participation ... and SNU Bio Angel. This new funding brings the ... (US $27.7M) since its founding in 2015. ... development and commercialization of its immuno-oncology programs, expand its ...
(Date:12/8/2016)... 2016   Biocept, Inc . (NASDAQ: ... clinically actionable liquid biopsy tests to improve the ... featuring its Target Selector™ Circulating Tumor Cell platform ... detection of actionable biomarkers in patients with metastatic ... Sara Cannon Research Institute (SCRI), the research arm ...
(Date:12/7/2016)... McLean, VA (PRWEB) , ... December 07, 2016 ... ... peer-reviewed medical journal has concluded that “in the setting of previously treated, advanced ... Further refinement in defining the optimal patient population and timing of blood sampling ...
Breaking Biology Technology: